This is the authors' abstract. We don't add key points for this paper.
In HCC patients receiving treatment, TARE using Y-90 resin microspheres may achieve comparable effectiveness outcomes compared with AB.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Agirrezabal et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: